Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-07-10

Clinical Trial Update: Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Meloxicam SoluMatrix Capsules with Meloxicam Tablets for osteoarthritis pain has been withdrawn. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meloxicam SoluMatrix Capsules (meloxicam)
  • Meloxicam Tablets (meloxicam)

Snippet

Sponsor: Iroko Pharmaceuticals, LLC | Conditions: Osteoarthritis | Phase 2 | Status: WITHDRAWN